Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Nephron Blog
June 7, 2023
Protected: Bioprocessing Industry KOL Call – June 6th – REPLAY
June 5, 2023
Protected: State of the Tools & Dx Industry – It is Still Too Early to Call the Bottom – June 2nd – REPLAY
May 12, 2023
Protected: Outlook for Lawsuit Challenging Power of CMS, HHS & Other Regulators to Set Government Policy – May 11th – REPLAY
April 24, 2023
Protected: Broad Institute Discussion on NGS Innovation & Genomics – Apr. 21 – REPLAY
April 13, 2023
Protected: Nephron FDA KOL Call on CRC Liquid Biopsy Tests – Apr. 12th – REPLAY
April 6, 2023
Protected: Nephron NGS industry KOL Discussion – Apr. 5th – REPLAY
March 21, 2023
340B Pharmacy Tailwind/Manufacturer Headwind Poised to Reverse in 2H 2023
March 6, 2023
Protected: Generic Market Dynamics Expert Call – Mar. 3rd – REPLAY
February 25, 2023
Comprehensive Market Update – CRO Industry 2023
February 17, 2023
Protected: Nephron MA Innovation Series: René Lerer – CEO Longevity Health Plan – Feb. 15th – REPLAY
February 14, 2023
MedTech Matchmaker – 5 Deal Ideas for 2023
February 9, 2023
Nephron Research Ranked #1 By Institutional Investor
February 7, 2023
Next Big Things: Why Pulsed Field Ablation Will Revolutionize the Treatment of AF
February 7, 2023
Protected: Understanding the PFA Competitive Landscape – Feb. 7th – REPLAY
February 3, 2023
Protected: Nephron Expert Call: Humira Biosimilar Launch Dynamics – Feb. 3rd – REPLAY
Posts navigation
<<
1
…
3
4
5
…
16
>>